메뉴 건너뛰기




Volumn 6, Issue 5, 1996, Pages 272-275

Preventing recurrence and progression in superficial bladder cancer

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; ALPHA2 INTERFERON; BCG VACCINE; BROPIRIMINE; DOXORUBICIN; EPIRUBICIN; ETOGLUCID; IMMUNOMODULATING AGENT; KEYHOLE LIMPET HEMOCYANIN; MITOMYCIN; MITOXANTRONE; PYRIDOXINE; THIOTEPA;

EID: 0029801304     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199609000-00009     Document Type: Short Survey
Times cited : (29)

References (25)
  • 1
    • 0029050331 scopus 로고
    • Intravesical mitozantrone in recurrent superficial bladder cancer: A phase II study
    • Namasivayam S, Whelan P: Intravesical mitozantrone in recurrent • superficial bladder cancer: a phase II study. Br J Urol 1995, 75:740-743. The first description of phase II results with a new active intravesical agent.
    • (1995) Br J Urol , vol.75 , pp. 740-743
    • Namasivayam, S.1    Whelan, P.2
  • 2
    • 0029153752 scopus 로고    scopus 로고
    • Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction
    • Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, •• Groshen S, Lieskovsky G, Boyd SD, Skinner DG: Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1996, 76:833-839. A good assessment of the prognostic factors, which may dictate the need for early radical surgery.
    • (1996) Cancer , vol.76 , pp. 833-839
    • Freeman, J.A.1    Esrig, D.2    Stein, J.P.3    Simoneau, A.R.4    Skinner, E.C.5    Chen, S.C.6    Groshen, S.7    Lieskovsky, G.8    Boyd, S.D.9    Skinner, D.G.10
  • 3
    • 0028946881 scopus 로고
    • Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transition cell carcinoma of the bladder
    • Lamm DL, Riggs DR, Traynelis CL, Nseyo UO: Apparent failure of •• current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transition cell carcinoma of the bladder. J Urol 1995, 53:1444-1450. This retrospective analysis of many studies of intravesical chemotherapy shows that, currently, no agent has influenced the rate of progression in superficial bladder cancer.
    • (1995) J Urol , vol.53 , pp. 1444-1450
    • Lamm, D.L.1    Riggs, D.R.2    Traynelis, C.L.3    Nseyo, U.O.4
  • 4
    • 0028900687 scopus 로고
    • Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
    • Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S, and the BLP •• Study Group: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol 1995, 27:104-109. First prospective randomized study of Lactobacillus casei showing a significant effect of this agent.
    • (1995) Eur Urol , vol.27 , pp. 104-109
    • Aso, Y.1    Akaza, H.2    Kotake, T.3    Tsukamoto, T.4    Imai, K.5    Naito, S.6
  • 6
    • 0029315694 scopus 로고
    • Chemotherapy and immunotherapy: How do we assess their effectiveness and what are their limitations and uses?
    • Lamm DL, Van der Meijden APM, Akaza H: Chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses? Int J Urol 1995, 2(suppl 2):23-33.
    • (1995) Int J Urol , vol.2 , Issue.2 SUPPL. , pp. 23-33
    • Lamm, D.L.1    Van Der Meijden, A.P.M.2    Akaza, H.3
  • 7
    • 0000420318 scopus 로고
    • Current status of intravesical therapy for bladder cancer
    • Edited by Ruysch S. New York, WW North & Co.;
    • Traynelis CL, Lamm DL: Current status of intravesical therapy for bladder cancer. In Urology Annual. Edited by Ruysch S. New York, WW North & Co.; 1994:113-143.
    • (1994) Urology Annual , pp. 113-143
    • Traynelis, C.L.1    Lamm, D.L.2
  • 8
    • 0004643513 scopus 로고
    • Adjuvant therapy of superficial transitional cell carcinoma - An EORTC randomized trial comparing doxorubicin, ethoglucid and TUR alone
    • Edited by Schröder FH, Ricards B. New York: Alan R. Liss
    • Kurth KH, Schröder FH, Senge T, De Bruyne FMJ, Carpentier PJ, Riedl H, Sylvester R, de Paul M and members of the EORTC GU-Group: Adjuvant therapy of superficial transitional cell carcinoma - an EORTC randomized trial comparing doxorubicin, ethoglucid and TUR alone. In Superficial Bladder Tumours. Edited by Schröder FH, Ricards B. New York: Alan R. Liss, 1985: 135-142.
    • (1985) Superficial Bladder Tumours , pp. 135-142
    • Kurth, K.H.1    Schröder, F.H.2    Senge, T.3    De Bruyne, F.M.J.4    Carpentier, P.J.5    Riedl, H.6    Sylvester, R.7    De Paul, M.8
  • 9
    • 0028946881 scopus 로고
    • Apparent failure of current intravesical chemotherapy prophylaxis to influence the long term course of superficial transitional cell carcinoma of the bladder
    • Lamm DL, Riggs DR, Traynelis CL, Nseyo UO: Apparent failure of current intravesical chemotherapy prophylaxis to influence the long term course of superficial transitional cell carcinoma of the bladder. J Urol 1995, 153:1444-1450.
    • (1995) J Urol , vol.153 , pp. 1444-1450
    • Lamm, D.L.1    Riggs, D.R.2    Traynelis, C.L.3    Nseyo, U.O.4
  • 10
    • 0027506241 scopus 로고
    • An EORTC GU-Group randomized trial comparing TUR followed by a single instillation of epirublcln or water in single stage Ta T1 carcinoma of the bladder
    • Oosterlinck W, Kurth KH, Schröder FH, Bultinck J, Hammond B, Sylvester R, and members of the EORTC GU-Group. An EORTC GU-Group randomized trial comparing TUR followed by a single instillation of epirublcln or water in single stage Ta T1 carcinoma of the bladder. J Urol 1993, 149:749-752.
    • (1993) J Urol , vol.149 , pp. 749-752
    • Oosterlinck, W.1    Kurth, K.H.2    Schröder, F.H.3    Bultinck, J.4    Hammond, B.5    Sylvester, R.6
  • 11
    • 0023629845 scopus 로고
    • Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer
    • The Japanese Urological Cancer Research Group for Adriamycin.
    • Akaza H, Isaka S, Koiso K, Kotake T, Machida T, Maru A, Matsumura Y, Niijima T, Obata K, Ohe H, et al.: The Japanese Urological Cancer Research Group for Adriamycin. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Cancer Chemother Pharmacol 1987, Suppl 20:91-96.
    • (1987) Cancer Chemother Pharmacol , vol.20 SUPPL , pp. 91-96
    • Akaza, H.1    Isaka, S.2    Koiso, K.3    Kotake, T.4    Machida, T.5    Maru, A.6    Matsumura, Y.7    Niijima, T.8    Obata, K.9    Ohe, H.10
  • 12
    • 0028909214 scopus 로고
    • Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Results of 2 EORTC randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short term versus long term treatment
    • Bouffioux, Kurth KH, Bono A, Oosterlinck C, Boeken Kruger W, de Paul M, Sylvester R, and the members of the EORTC GU-Group: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 EORTC randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short term versus long term treatment J Urol 1995, 153:934-941.
    • (1995) J Urol , vol.153 , pp. 934-941
    • Bouffioux1    Kurth, K.H.2    Bono, A.3    Oosterlinck, C.4    Boeken Kruger, W.5    De Paul, M.6    Sylvester, R.7
  • 13
    • 10244256788 scopus 로고
    • Intracavitary BCG in the treatment of superficial bladder tumours
    • Morales A, Eidinger, Bruce AW: Intracavitary BCG in the treatment of superficial bladder tumours. J Urol 1976, 116:18-23.
    • (1976) J Urol , vol.116 , pp. 18-23
    • Morales, A.1    Eidinger2    Bruce, A.W.3
  • 14
    • 0028962090 scopus 로고
    • BCG in perspective: Advances in the treatment of superficial bladder cancer
    • Lamm DL. BCG in perspective: advances in the treatment of •• superficial bladder cancer. Eur Urol 1995, 27(suppl 1):2-8. A useful update of a knowledge of BCG therapy, including the question of maintenance dosing.
    • (1995) Eur Urol , vol.27 , Issue.1 SUPPL. , pp. 2-8
    • Lamm, D.L.1
  • 17
    • 0028967945 scopus 로고
    • Practical approaches to the prevention and treatment of adverse reactions to BCG
    • Van der Meijden APM: Practical approaches to the prevention and treatment of adverse reactions to BCG. Eur Urol 1995, 27(suppl 1):23-28.
    • (1995) Eur Urol , vol.27 , Issue.1 SUPPL. , pp. 23-28
    • Van Der Meijden, A.P.M.1
  • 18
    • 0028948874 scopus 로고
    • Low dose BCG therapy in superficial high risk bladder cancer: A phase II study with BCG strain Connaught Canada
    • Mack D, Fnck J: Low dose BCG therapy in superficial high risk bladder cancer: a phase II study with BCG strain Connaught Canada. Br J Urol 1995, 75:185-187.
    • (1995) Br J Urol , vol.75 , pp. 185-187
    • Mack, D.1    Fnck, J.2
  • 20
    • 0029053868 scopus 로고
    • Intravesical BCG therapy prevents tumour progression and death from superficial bladder cancer: Ten year follow-up of a prospective randomized trial
    • Herr HW, Schwalb DM, Zhang ZF, Sogani PC, Fair WR, Whitmore jr. •• WF, Oettgen HF: Intravesical BCG therapy prevents tumour progression and death from superficial bladder cancer: ten year follow-up of a prospective randomized trial. J Clin Oncol 1995, 13:1404-1408. An important study showing quite clearly that BCG influences the rate of progression in superficial bladder cancer.
    • (1995) J Clin Oncol , vol.13 , pp. 1404-1408
    • Herr, H.W.1    Schwalb, D.M.2    Zhang, Z.F.3    Sogani, P.C.4    Fair, W.R.5    Whitmore Jr., W.F.6    Oettgen, H.F.7
  • 21
    • 10244266781 scopus 로고
    • Intravesical prophylaxis with BCG versus interferon α for superficial bladder cancer
    • Kalbe T, Boer M, Staehler G: Intravesical prophylaxis with BCG versus interferon α for superficial bladder cancer [Abstract]. J Urol 1994, 151:233.
    • (1994) J Urol , vol.151 , pp. 233
    • Kalbe, T.1    Boer, M.2    Staehler, G.3
  • 22
    • 0023934840 scopus 로고
    • Immunotherapy in bladder with KLH - A randomized study
    • Jarinciu CD, Engelmann U, Gasch J, Klippel KF: Immunotherapy in bladder with KLH - a randomized study. J Urol 1988, 139:723-726.
    • (1988) J Urol , vol.139 , pp. 723-726
    • Jarinciu, C.D.1    Engelmann, U.2    Gasch, J.3    Klippel, K.F.4
  • 23
    • 0028947819 scopus 로고
    • Trypthophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective randomized phase III study performed by the EORTC GU-Group
    • Newling DWW, Robinson MRG, Smith PH, Byar D, Lockwood R, Stevens I, De Pauw M, Sylvester R, and members of the EORTC GU-Group: Trypthophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective randomized phase III study performed by the EORTC GU-Group. Eur Urol 1995, 27:110-116.
    • (1995) Eur Urol , vol.27 , pp. 110-116
    • Newling, D.W.W.1    Robinson, M.R.G.2    Smith, P.H.3    Byar, D.4    Lockwood, R.5    Stevens, I.6    De Pauw, M.7    Sylvester, R.8
  • 24
    • 0017657105 scopus 로고
    • Comparison of pyridoxine, placebo and topical thlotepa in presenting recurrence of stage I bladder carcinoma
    • Byar D, Blackhard C: Comparison of pyridoxine, placebo and topical thlotepa in presenting recurrence of stage I bladder carcinoma. Urology 1977, 10:556-560.
    • (1977) Urology , vol.10 , pp. 556-560
    • Byar, D.1    Blackhard, C.2
  • 25
    • 0029665257 scopus 로고    scopus 로고
    • Marker tumour response to the sequential combination of intravesical therapy with MMC and BCG-RIVM in multiple superficial bladder tumours
    • Van der Meijden APM, Hall RR, Pavone Maculuso M, Pawinsky A, Sylvester R, Van Glabbeke M: Marker tumour response to the sequential combination of intravesical therapy with MMC and BCG-RIVM in multiple superficial bladder tumours. Eur Urol 1996, 29:199-203.
    • (1996) Eur Urol , vol.29 , pp. 199-203
    • Van Der Meijden, A.P.M.1    Hall, R.R.2    Pavone Maculuso, M.3    Pawinsky, A.4    Sylvester, R.5    Van Glabbeke, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.